HEADER LIPID BINDING PROTEIN 26-JUL-05 2AG2 TITLE CRYSTAL STRUCTURE ANALYSIS OF GM2-ACTIVATOR PROTEIN COMPLEXED WITH TITLE 2 PHOSPHATIDYLCHOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GANGLIOSIDE GM2 ACTIVATOR; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: GM2-AP; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER, BRAIN, NEURONS; SOURCE 6 GENE: GM2A; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET16B (NOVAGEN) KEYWDS PHOSPHOLIPID-PROTEIN COMPLEX, LIPID ACYL CHAIN STACKING, PACKAGING, KEYWDS 2 LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.S.WRIGHT,L.Z.MI,S.LEE,F.RASTINEJAD REVDAT 6 20-NOV-24 2AG2 1 REMARK REVDAT 5 23-AUG-23 2AG2 1 REMARK SEQADV REVDAT 4 13-JUL-11 2AG2 1 VERSN REVDAT 3 08-SEP-09 2AG2 1 HETNAM REVDAT 2 24-FEB-09 2AG2 1 VERSN REVDAT 1 25-OCT-05 2AG2 0 JRNL AUTH C.S.WRIGHT,L.Z.MI,S.LEE,F.RASTINEJAD JRNL TITL CRYSTAL STRUCTURE ANALYSIS OF JRNL TITL 2 PHOSPHATIDYLCHOLINE-GM2-ACTIVATOR PRODUCT COMPLEXES: JRNL TITL 3 EVIDENCE FOR HYDROLASE ACTIVITY. JRNL REF BIOCHEMISTRY V. 44 13510 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 16216074 JRNL DOI 10.1021/BI050668W REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.S.WRIGHT,S.C.LI,F.RASTINEJAD REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN GM2- ACTIVATOR PROTEIN WITH A REMARK 1 TITL 2 NOVEL BETA-CUP TOPOLOGY REMARK 1 REF J.MOL.BIOL. V. 304 411 2000 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 11090283 REMARK 1 DOI 10.1006/JMBI.2000.4225 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.S.WRIGHT,Q.ZHAO,F.RASTINEJAD REMARK 1 TITL STRUCTURE ANALYSIS OF LIPID COMPLEXES OF GM2-ACTIVATOR REMARK 1 TITL 2 PROTEIN REMARK 1 REF J.MOL.BIOL. V. 331 951 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12909021 REMARK 1 DOI 10.1016/S0022-2836(03)00794-0 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.S.WRIGHT,L.Z.MI,F.RASTINEJAD REMARK 1 TITL EVIDENCE FOR LIPID PACKAGING IN THE CRYSTAL STRUCTURE OF THE REMARK 1 TITL 2 GM2-ACTIVATOR COMPLEX WITH PLATELET ACTIVATING FACTOR REMARK 1 REF J.MOL.BIOL. V. 342 585 2004 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1945871.480 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 45347 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2287 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7057 REMARK 3 BIN R VALUE (WORKING SET) : 0.1920 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 380 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3714 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 331 REMARK 3 SOLVENT ATOMS : 594 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.78000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : -0.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.07 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.980 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.410 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.420 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 10.170; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.250 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 54.44 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : SOLVENT_REP.PARAM REMARK 3 PARAMETER FILE 4 : OLA_LPC_MYR_LAU_EPE_CHL.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : SOLVENT.TOP REMARK 3 TOPOLOGY FILE 4 : OLA_LPC_MYR_LAU_EPE_CHL.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AG2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000033849. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 123 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61655 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : 0.06700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.40700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY: 1PU5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, HEPES, ISOPROPANOL, PH 7.6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.76500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.24000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.09500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.24000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.76500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.09500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS C 1 REMARK 465 MET C 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 1 CB CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 1 CB CG ND1 CD2 CE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 127 CB CG OD1 OD2 REMARK 480 GLU A 129 CB CG CD OE1 OE2 REMARK 480 LYS B 14 CG CD CE NZ REMARK 480 GLU B 129 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 151 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 11 66.41 -153.46 REMARK 500 TYR B 73 -8.27 73.17 REMARK 500 CYS B 107 19.12 -143.38 REMARK 500 CYS C 107 21.87 -145.70 REMARK 500 PRO C 126 92.76 -32.34 REMARK 500 ASP C 127 165.26 -33.38 REMARK 500 LEU C 128 -178.01 -35.79 REMARK 500 PRO C 131 155.22 -46.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 OLA B 3628 REMARK 615 OLA C 3629 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE C 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CH5 B 2341 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CH5 C 2342 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LP3 B 2343 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LP3 A 2344 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LP3 A 2345 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LP3 C 2346 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA B 3628 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA C 3629 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR C 3045 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR B 3046 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DAO B 1364 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 1502 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 1504 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA B 1508 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA B 1509 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 1510 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 1511 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 1512 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 1513 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 1514 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA B 1515 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G13 RELATED DB: PDB REMARK 900 APO-PROTEIN STRUCTURE WITH SAME CELL PARAMETERS REMARK 900 RELATED ID: 1PUB RELATED DB: PDB REMARK 900 APO-PROTEIN STRUCTURE CRYSTALLIZED AT PH 5.5 WITH DIFFERENT CELL REMARK 900 RELATED ID: 1PU5 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH GM2 GANGLIOSIDE; SAME CELL PARAMETERS REMARK 900 RELATED ID: 1TJJ RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH PLATELET ACTIVATING FACTOR (PAF); SAME REMARK 900 CELL PARAMETERS DBREF 2AG2 A 3 164 UNP P17900 SAP3_HUMAN 32 193 DBREF 2AG2 B 3 164 UNP P17900 SAP3_HUMAN 32 193 DBREF 2AG2 C 3 164 UNP P17900 SAP3_HUMAN 32 193 SEQADV 2AG2 HIS A 1 UNP P17900 CLONING ARTIFACT SEQADV 2AG2 MET A 2 UNP P17900 CLONING ARTIFACT SEQADV 2AG2 HIS B 1 UNP P17900 CLONING ARTIFACT SEQADV 2AG2 MET B 2 UNP P17900 CLONING ARTIFACT SEQADV 2AG2 HIS C 1 UNP P17900 CLONING ARTIFACT SEQADV 2AG2 MET C 2 UNP P17900 CLONING ARTIFACT SEQRES 1 A 164 HIS MET SER SER PHE SER TRP ASP ASN CYS ASP GLU GLY SEQRES 2 A 164 LYS ASP PRO ALA VAL ILE ARG SER LEU THR LEU GLU PRO SEQRES 3 A 164 ASP PRO ILE VAL VAL PRO GLY ASN VAL THR LEU SER VAL SEQRES 4 A 164 VAL GLY SER THR SER VAL PRO LEU SER SER PRO LEU LYS SEQRES 5 A 164 VAL ASP LEU VAL LEU GLU LYS GLU VAL ALA GLY LEU TRP SEQRES 6 A 164 ILE LYS ILE PRO CYS THR ASP TYR ILE GLY SER CYS THR SEQRES 7 A 164 PHE GLU HIS PHE CYS ASP VAL LEU ASP MET LEU ILE PRO SEQRES 8 A 164 THR GLY GLU PRO CYS PRO GLU PRO LEU ARG THR TYR GLY SEQRES 9 A 164 LEU PRO CYS HIS CYS PRO PHE LYS GLU GLY THR TYR SER SEQRES 10 A 164 LEU PRO LYS SER GLU PHE VAL VAL PRO ASP LEU GLU LEU SEQRES 11 A 164 PRO SER TRP LEU THR THR GLY ASN TYR ARG ILE GLU SER SEQRES 12 A 164 VAL LEU SER SER SER GLY LYS ARG LEU GLY CYS ILE LYS SEQRES 13 A 164 ILE ALA ALA SER LEU LYS GLY ILE SEQRES 1 B 164 HIS MET SER SER PHE SER TRP ASP ASN CYS ASP GLU GLY SEQRES 2 B 164 LYS ASP PRO ALA VAL ILE ARG SER LEU THR LEU GLU PRO SEQRES 3 B 164 ASP PRO ILE VAL VAL PRO GLY ASN VAL THR LEU SER VAL SEQRES 4 B 164 VAL GLY SER THR SER VAL PRO LEU SER SER PRO LEU LYS SEQRES 5 B 164 VAL ASP LEU VAL LEU GLU LYS GLU VAL ALA GLY LEU TRP SEQRES 6 B 164 ILE LYS ILE PRO CYS THR ASP TYR ILE GLY SER CYS THR SEQRES 7 B 164 PHE GLU HIS PHE CYS ASP VAL LEU ASP MET LEU ILE PRO SEQRES 8 B 164 THR GLY GLU PRO CYS PRO GLU PRO LEU ARG THR TYR GLY SEQRES 9 B 164 LEU PRO CYS HIS CYS PRO PHE LYS GLU GLY THR TYR SER SEQRES 10 B 164 LEU PRO LYS SER GLU PHE VAL VAL PRO ASP LEU GLU LEU SEQRES 11 B 164 PRO SER TRP LEU THR THR GLY ASN TYR ARG ILE GLU SER SEQRES 12 B 164 VAL LEU SER SER SER GLY LYS ARG LEU GLY CYS ILE LYS SEQRES 13 B 164 ILE ALA ALA SER LEU LYS GLY ILE SEQRES 1 C 164 HIS MET SER SER PHE SER TRP ASP ASN CYS ASP GLU GLY SEQRES 2 C 164 LYS ASP PRO ALA VAL ILE ARG SER LEU THR LEU GLU PRO SEQRES 3 C 164 ASP PRO ILE VAL VAL PRO GLY ASN VAL THR LEU SER VAL SEQRES 4 C 164 VAL GLY SER THR SER VAL PRO LEU SER SER PRO LEU LYS SEQRES 5 C 164 VAL ASP LEU VAL LEU GLU LYS GLU VAL ALA GLY LEU TRP SEQRES 6 C 164 ILE LYS ILE PRO CYS THR ASP TYR ILE GLY SER CYS THR SEQRES 7 C 164 PHE GLU HIS PHE CYS ASP VAL LEU ASP MET LEU ILE PRO SEQRES 8 C 164 THR GLY GLU PRO CYS PRO GLU PRO LEU ARG THR TYR GLY SEQRES 9 C 164 LEU PRO CYS HIS CYS PRO PHE LYS GLU GLY THR TYR SER SEQRES 10 C 164 LEU PRO LYS SER GLU PHE VAL VAL PRO ASP LEU GLU LEU SEQRES 11 C 164 PRO SER TRP LEU THR THR GLY ASN TYR ARG ILE GLU SER SEQRES 12 C 164 VAL LEU SER SER SER GLY LYS ARG LEU GLY CYS ILE LYS SEQRES 13 C 164 ILE ALA ALA SER LEU LYS GLY ILE HET CL A 801 1 HET EPE A 900 15 HET LP3 A2344 35 HET LP3 A2345 35 HET IPA A1502 4 HET IPA A1504 4 HET CL B 802 1 HET CH5 B2341 16 HET LP3 B2343 35 HET OLA B3628 20 HET MYR B3046 16 HET DAO B1364 14 HET IPA B1508 4 HET IPA B1509 4 HET IPA B1515 4 HET CL C 803 1 HET EPE C 901 15 HET CH5 C2342 16 HET LP3 C2346 35 HET OLA C3629 20 HET MYR C3045 16 HET IPA C1510 4 HET IPA C1511 4 HET IPA C1512 4 HET IPA C1513 4 HET IPA C1514 4 HETNAM CL CHLORIDE ION HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM LP3 (7R)-4,7-DIHYDROXY-N,N,N-TRIMETHYL-10-OXO-3,5,9-TRIOXA- HETNAM 2 LP3 4-PHOSPHAHEPTACOSAN-1-AMINIUM 4-OXIDE HETNAM IPA ISOPROPYL ALCOHOL HETNAM CH5 2-(((R)-2,3-DIHYDROXYPROPYL)PHOSPHORYLOXY)-N,N,N- HETNAM 2 CH5 TRIMETHYLETHANAMINIUM HETNAM OLA OLEIC ACID HETNAM MYR MYRISTIC ACID HETNAM DAO LAURIC ACID HETSYN EPE HEPES HETSYN IPA 2-PROPANOL HETSYN CH5 GLYCERO-3-PHOSPHOCHOLINE FORMUL 4 CL 3(CL 1-) FORMUL 5 EPE 2(C8 H18 N2 O4 S) FORMUL 6 LP3 4(C26 H55 N O7 P 1+) FORMUL 8 IPA 10(C3 H8 O) FORMUL 11 CH5 2(C8 H21 N O6 P 1+) FORMUL 13 OLA 2(C18 H34 O2) FORMUL 14 MYR 2(C14 H28 O2) FORMUL 15 DAO C12 H24 O2 FORMUL 30 HOH *594(H2 O) HELIX 1 1 HIS A 81 ILE A 90 1 10 HELIX 2 2 PRO A 131 THR A 136 1 6 HELIX 3 3 HIS B 81 ILE B 90 1 10 HELIX 4 4 PRO B 131 THR B 136 1 6 HELIX 5 5 HIS C 81 ILE C 90 1 10 SHEET 1 A 5 SER A 6 ASN A 9 0 SHEET 2 A 5 LYS A 150 GLY A 163 -1 O LYS A 156 N ASP A 8 SHEET 3 A 5 GLY A 137 SER A 147 -1 N LEU A 145 O GLY A 153 SHEET 4 A 5 LYS A 52 VAL A 61 -1 N LYS A 52 O SER A 146 SHEET 5 A 5 LEU A 64 ILE A 68 -1 O LEU A 64 N VAL A 61 SHEET 1 B 5 ILE A 29 VAL A 31 0 SHEET 2 B 5 LYS A 150 GLY A 163 1 O SER A 160 N ILE A 29 SHEET 3 B 5 GLY A 137 SER A 147 -1 N LEU A 145 O GLY A 153 SHEET 4 B 5 LYS A 52 VAL A 61 -1 N LYS A 52 O SER A 146 SHEET 5 B 5 THR A 78 PHE A 79 -1 O PHE A 79 N VAL A 53 SHEET 1 C 3 ALA A 17 GLU A 25 0 SHEET 2 C 3 ASN A 34 THR A 43 -1 O VAL A 40 N ARG A 20 SHEET 3 C 3 GLY A 114 VAL A 124 -1 O TYR A 116 N GLY A 41 SHEET 1 D 5 SER B 6 ASN B 9 0 SHEET 2 D 5 LYS B 150 GLY B 163 -1 O ALA B 158 N SER B 6 SHEET 3 D 5 GLY B 137 SER B 147 -1 N LEU B 145 O LEU B 152 SHEET 4 D 5 LYS B 52 VAL B 61 -1 N LYS B 52 O SER B 146 SHEET 5 D 5 LEU B 64 ILE B 68 -1 O LEU B 64 N VAL B 61 SHEET 1 E 5 ILE B 29 VAL B 31 0 SHEET 2 E 5 LYS B 150 GLY B 163 1 O SER B 160 N ILE B 29 SHEET 3 E 5 GLY B 137 SER B 147 -1 N LEU B 145 O LEU B 152 SHEET 4 E 5 LYS B 52 VAL B 61 -1 N LYS B 52 O SER B 146 SHEET 5 E 5 THR B 78 PHE B 79 -1 O PHE B 79 N VAL B 53 SHEET 1 F 3 ALA B 17 GLU B 25 0 SHEET 2 F 3 ASN B 34 THR B 43 -1 O VAL B 40 N ARG B 20 SHEET 3 F 3 GLY B 114 VAL B 124 -1 O TYR B 116 N GLY B 41 SHEET 1 G 5 SER C 6 ASN C 9 0 SHEET 2 G 5 LYS C 150 LYS C 162 -1 O LYS C 156 N ASP C 8 SHEET 3 G 5 GLY C 137 SER C 147 -1 N LEU C 145 O GLY C 153 SHEET 4 G 5 LYS C 52 VAL C 61 -1 N LYS C 52 O SER C 146 SHEET 5 G 5 LEU C 64 LYS C 67 -1 O LEU C 64 N VAL C 61 SHEET 1 H 5 ILE C 29 VAL C 30 0 SHEET 2 H 5 LYS C 150 LYS C 162 1 O SER C 160 N ILE C 29 SHEET 3 H 5 GLY C 137 SER C 147 -1 N LEU C 145 O GLY C 153 SHEET 4 H 5 LYS C 52 VAL C 61 -1 N LYS C 52 O SER C 146 SHEET 5 H 5 THR C 78 PHE C 79 -1 O PHE C 79 N VAL C 53 SHEET 1 I 3 ALA C 17 GLU C 25 0 SHEET 2 I 3 ASN C 34 THR C 43 -1 O VAL C 40 N ARG C 20 SHEET 3 I 3 GLY C 114 VAL C 124 -1 O TYR C 116 N GLY C 41 SSBOND 1 CYS A 10 CYS A 154 1555 1555 2.07 SSBOND 2 CYS A 70 CYS A 77 1555 1555 2.03 SSBOND 3 CYS A 83 CYS A 109 1555 1555 2.06 SSBOND 4 CYS A 96 CYS A 107 1555 1555 2.07 SSBOND 5 CYS B 10 CYS B 154 1555 1555 2.07 SSBOND 6 CYS B 70 CYS B 77 1555 1555 2.05 SSBOND 7 CYS B 83 CYS B 109 1555 1555 2.03 SSBOND 8 CYS B 96 CYS B 107 1555 1555 2.04 SSBOND 9 CYS C 10 CYS C 154 1555 1555 2.05 SSBOND 10 CYS C 70 CYS C 77 1555 1555 2.04 SSBOND 11 CYS C 83 CYS C 109 1555 1555 2.03 SSBOND 12 CYS C 96 CYS C 107 1555 1555 2.06 CISPEP 1 GLU A 25 PRO A 26 0 -0.46 CISPEP 2 ASP A 27 PRO A 28 0 0.33 CISPEP 3 VAL A 31 PRO A 32 0 -0.34 CISPEP 4 SER A 49 PRO A 50 0 -0.31 CISPEP 5 GLU A 98 PRO A 99 0 0.61 CISPEP 6 CYS A 109 PRO A 110 0 -0.31 CISPEP 7 GLU B 25 PRO B 26 0 -0.45 CISPEP 8 ASP B 27 PRO B 28 0 0.30 CISPEP 9 VAL B 31 PRO B 32 0 -0.08 CISPEP 10 SER B 49 PRO B 50 0 -0.14 CISPEP 11 GLU B 98 PRO B 99 0 0.00 CISPEP 12 CYS B 109 PRO B 110 0 0.00 CISPEP 13 GLU C 25 PRO C 26 0 -0.42 CISPEP 14 ASP C 27 PRO C 28 0 0.43 CISPEP 15 VAL C 31 PRO C 32 0 -0.18 CISPEP 16 SER C 49 PRO C 50 0 0.22 CISPEP 17 GLU C 98 PRO C 99 0 0.03 CISPEP 18 CYS C 109 PRO C 110 0 -0.22 SITE 1 AC1 6 SER A 49 PRO A 50 LEU A 51 HIS A 81 SITE 2 AC1 6 CYS A 83 HOH C3701 SITE 1 AC2 6 HOH A2495 SER B 49 PRO B 50 LEU B 51 SITE 2 AC2 6 HIS B 81 CYS B 83 SITE 1 AC3 4 SER C 49 LEU C 51 HIS C 81 CYS C 83 SITE 1 AC4 7 SER A 6 TRP A 7 GLU A 12 HOH A2357 SITE 2 AC4 7 HOH A2432 HOH A2441 HOH A2469 SITE 1 AC5 6 SER C 6 TRP C 7 ASP C 8 GLU C 12 SITE 2 AC5 6 HOH C3767 HOH C3774 SITE 1 AC6 15 TRP A 133 LEU A 134 LEU B 57 LYS B 59 SITE 2 AC6 15 ILE B 68 ILE B 74 LEU B 128 LEU B 130 SITE 3 AC6 15 LEU B 134 TYR B 139 LEU B 161 DAO B1364 SITE 4 AC6 15 IPA B1509 OLA B3628 HOH B3802 SITE 1 AC7 8 GLY A 63 LEU B 64 TYR C 73 PHE C 82 SITE 2 AC7 8 MET C 88 LEU C 89 MYR C3045 HOH C3820 SITE 1 AC8 15 ALA B 17 VAL B 18 ILE B 19 GLY B 41 SITE 2 AC8 15 VAL B 53 PRO B 97 PRO B 106 PHE B 111 SITE 3 AC8 15 TYR B 116 SER B 143 LEU B 145 GLY B 153 SITE 4 AC8 15 ILE B 155 IPA B1508 MYR B3046 SITE 1 AC9 17 LEU A 24 VAL A 39 LEU A 57 ILE A 68 SITE 2 AC9 17 ILE A 74 LEU A 100 LEU A 130 TYR A 139 SITE 3 AC9 17 ILE A 155 ILE A 157 LEU A 161 IPA A1504 SITE 4 AC9 17 LP3 A2345 HOH A2478 HOH A2504 HOH A2516 SITE 5 AC9 17 HOH A2518 SITE 1 BC1 18 ALA A 17 VAL A 18 GLY A 41 SER A 42 SITE 2 BC1 18 LEU A 47 VAL A 53 LEU A 55 PHE A 82 SITE 3 BC1 18 PRO A 106 TYR A 116 SER A 143 VAL A 144 SITE 4 BC1 18 LEU A 145 ILE A 155 IPA A1502 IPA A1504 SITE 5 BC1 18 LP3 A2344 HOH A2528 SITE 1 BC2 16 ALA C 17 VAL C 18 ILE C 19 GLY C 41 SITE 2 BC2 16 SER C 42 VAL C 53 PRO C 106 TYR C 116 SITE 3 BC2 16 SER C 143 VAL C 144 LEU C 145 GLY C 153 SITE 4 BC2 16 ILE C 155 IPA C1510 IPA C1512 HOH C3773 SITE 1 BC3 10 ILE B 19 LEU B 24 LEU B 37 VAL B 39 SITE 2 BC3 10 GLY B 41 TYR B 116 DAO B1364 IPA B1508 SITE 3 BC3 10 CH5 B2341 HOH B3802 SITE 1 BC4 7 LEU C 24 VAL C 39 TYR C 116 ILE C 141 SITE 2 BC4 7 ALA C 159 IPA C1511 MYR C3045 SITE 1 BC5 4 PHE C 123 VAL C 125 CH5 C2342 OLA C3629 SITE 1 BC6 5 LEU B 55 TYR B 73 PHE B 79 LP3 B2343 SITE 2 BC6 5 HOH B3820 SITE 1 BC7 8 ILE B 74 PHE B 123 VAL B 125 PRO B 126 SITE 2 BC7 8 LEU B 128 CH5 B2341 OLA B3628 HOH B3791 SITE 1 BC8 2 PHE A 111 LP3 A2345 SITE 1 BC9 3 ILE A 157 LP3 A2344 LP3 A2345 SITE 1 CC1 4 LEU B 47 PHE B 111 LP3 B2343 OLA B3628 SITE 1 CC2 4 GLY B 75 ILE B 141 CH5 B2341 HOH B3712 SITE 1 CC3 1 LP3 C2346 SITE 1 CC4 5 TRP C 133 LEU C 134 TYR C 139 LEU C 161 SITE 2 CC4 5 OLA C3629 SITE 1 CC5 1 LP3 C2346 SITE 1 CC6 1 LEU C 118 SITE 1 CC7 5 LEU C 55 TYR C 73 ILE C 74 GLY C 75 SITE 2 CC7 5 HOH C3820 SITE 1 CC8 2 CYS B 107 PHE B 111 CRYST1 63.530 86.190 120.480 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015741 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011602 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008300 0.00000